Jiang et al. similarly constructed a prognostic prediction model for bladder cancer, which was based on disulfidptosis-associated lncRNAs, and they found three genes (NDUFA11, RPN1, SLC3A2) that are disulfidptosis related, which could be potential novel biomarkers for bladder cancer diagnosis and treatment [15]. This evidence concerns the gene NDUFA11 and urinary bladder cancer.